Consistent with a role for protein degradation in this effect of BEZ235, co-treatment of NSCLC cells with the proteosome inhibitor MG132 partially rescued BEZ235-induced downregulation of cyclin D1 and cyclin D3 (Fig. 3a). This evidence concerns the gene CCND1 and non-small cell lung carcinoma.